Takeda, Swiss-Based Nycomed Said To Be In Acquisition Talks
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals reportedly is dealing with Nycomed to buy the closely held Swiss drug maker for more than $11.4 billion